Los puntos clave no están disponibles para este artículo en este momento.
Our findings support a model whereby distinct pathways are activated by MTX in T cells and FLSs to inhibit NF-κB activation.
Share your take
Add a clinician perspective alongside expert commentary.
Spurlock et al. (2014) studied this question.